Carmine Carpenito

9.2k total citations · 4 hit papers
37 papers, 5.8k citations indexed

About

Carmine Carpenito is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Carmine Carpenito has authored 37 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Carmine Carpenito's work include CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (10 papers) and Virus-based gene therapy research (9 papers). Carmine Carpenito is often cited by papers focused on CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (10 papers) and Virus-based gene therapy research (9 papers). Carmine Carpenito collaborates with scholars based in United States, Canada and Japan. Carmine Carpenito's co-authors include Carl H. June, Richard G. Carroll, James L. Riley, Chrystal M. Paulos, Michael C. Milone, Steven Μ. Albelda, Stephan A. Grupp, Zhiya Yu, Zoltán Pós and Ena Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Carmine Carpenito

37 papers receiving 5.7k citations

Hit Papers

A human memory T cell subset with stem cell–like properties 2009 2026 2014 2020 2011 2009 2009 2011 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmine Carpenito United States 22 4.3k 2.8k 1.6k 1.4k 1.2k 37 5.8k
Attilio Bondanza Italy 38 3.5k 0.8× 3.2k 1.1× 1.9k 1.2× 1.4k 1.0× 831 0.7× 100 6.3k
Rimas J. Orentas United States 34 6.6k 1.5× 2.9k 1.1× 2.2k 1.4× 2.0k 1.4× 1.9k 1.6× 120 8.2k
Tova Waks Israel 26 3.7k 0.9× 2.1k 0.8× 1.2k 0.8× 1.2k 0.8× 1.0k 0.8× 54 4.5k
Zhili Zheng United States 43 7.8k 1.8× 5.8k 2.1× 3.1k 1.9× 2.5k 1.8× 1.0k 0.9× 68 10.0k
Carolina Berger United States 28 3.0k 0.7× 1.5k 0.5× 1.2k 0.8× 1.1k 0.8× 782 0.6× 49 3.9k
Hinrich Abken Germany 58 8.0k 1.9× 4.7k 1.7× 2.8k 1.7× 2.4k 1.7× 2.3k 1.9× 219 10.2k
Karin Straathof United States 23 3.6k 0.8× 1.9k 0.7× 1.2k 0.8× 1.4k 0.9× 793 0.7× 38 4.6k
Marianna Sabatino United States 28 3.5k 0.8× 1.7k 0.6× 1.4k 0.8× 970 0.7× 896 0.7× 87 4.8k
Andrew Kaiser Germany 31 3.1k 0.7× 2.6k 0.9× 1.2k 0.7× 867 0.6× 546 0.5× 56 4.3k
Marc Cartellieri Germany 31 2.5k 0.6× 1.2k 0.4× 867 0.5× 691 0.5× 972 0.8× 68 3.2k

Countries citing papers authored by Carmine Carpenito

Since Specialization
Citations

This map shows the geographic impact of Carmine Carpenito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Carpenito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Carpenito more than expected).

Fields of papers citing papers by Carmine Carpenito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmine Carpenito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Carpenito. The network helps show where Carmine Carpenito may publish in the future.

Co-authorship network of co-authors of Carmine Carpenito

This figure shows the co-authorship network connecting the top 25 collaborators of Carmine Carpenito. A scholar is included among the top collaborators of Carmine Carpenito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmine Carpenito. Carmine Carpenito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poussin, Mathilde, Arlene Sereno, Xiufeng Wu, et al.. (2021). Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies. Journal for ImmunoTherapy of Cancer. 9(7). e002444–e002444. 21 indexed citations
2.
Bailey, Stefanie R., Michelle H. Nelson, Kinga Majchrzak, et al.. (2017). Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nature Communications. 8(1). 1961–1961. 73 indexed citations
3.
Frigault, Matthew J., Ji‐Hyun Lee, Maria C. Basil, et al.. (2015). Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells. Cancer Immunology Research. 3(4). 356–367. 233 indexed citations
4.
Guedan, Sònia, Xi Chen, Aviv Madar, et al.. (2014). ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells. Blood. 124(7). 1070–1080. 275 indexed citations
5.
Brennan, Andrea, Shuguang Jiang, Gwendolyn Binder-Scholl, et al.. (2013). Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5. Human Gene Therapy. 24(3). 245–258. 91 indexed citations
6.
Moon, Edmund K., Carmine Carpenito, Jing Sun, et al.. (2011). Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor. Clinical Cancer Research. 17(14). 4719–4730. 447 indexed citations breakdown →
7.
Ye, Qunrui, Carmine Carpenito, Mathilde Poussin, et al.. (2011). In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB). Cancer Research. 71(13). 4617–4627. 237 indexed citations
8.
Barrett, David M., Yangbing Zhao, Xiaojun Liu, et al.. (2011). Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells. Human Gene Therapy. 22(12). 1575–1586. 182 indexed citations
9.
Barrett, David M., Alix E. Seif, Carmine Carpenito, et al.. (2011). Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling. Blood. 118(15). e112–e117. 40 indexed citations
10.
Facciabene, Andrea, Marinos Tsiatas, Carmine Carpenito, et al.. (2011). Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. Journal of Translational Medicine. 9(1). 77–77. 44 indexed citations
11.
Zhao, Yangbing, Edmund K. Moon, Carmine Carpenito, et al.. (2010). Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor. Cancer Research. 70(22). 9053–9061. 366 indexed citations
12.
Facciabene, Andrea, Carmine Carpenito, Fabián Benencia, et al.. (2009). Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. Journal of Translational Medicine. 7(1). 104–104. 35 indexed citations
13.
Milone, Michael C., Jonathan D. Fish, Carmine Carpenito, et al.. (2009). Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo. Molecular Therapy. 17(8). 1453–1464. 893 indexed citations breakdown →
14.
Varela‐Rohena, Angel, Carmine Carpenito, Elena Pérez, et al.. (2008). Genetic engineering of T cells for adoptive immunotherapy. Immunologic Research. 42(1-3). 166–181. 51 indexed citations
15.
Wilson, Erica, Christine A. Parachoniak, Carmine Carpenito, Dixie L. Mager, & Fumio Takei. (2007). Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1+ T cells. Immunogenetics. 59(8). 641–651. 5 indexed citations
16.
Maeda, Motoi, Carmine Carpenito, Ryan C. Russell, et al.. (2005). Murine CD160, Ig-Like Receptor on NK Cells and NKT Cells, Recognizes Classical and Nonclassical MHC Class I and Regulates NK Cell Activation. The Journal of Immunology. 175(7). 4426–4432. 67 indexed citations
17.
Carpenito, Carmine, et al.. (2002). Exploiting the differential production of angiogenic factors within the tumor microenvironment in the design of a novel vascular-targeted gene therapy-based approach to the treatment of cancer. International Journal of Radiation Oncology*Biology*Physics. 54(5). 1473–1478. 12 indexed citations
18.
Carpenito, Carmine, et al.. (1997). The Role of LFA-1 (CD11a/CD18) Cytoplasmic Domains in Binding to Intercellular Adhesion Molecule-1 (CD54) and in Postreceptor Cell Spreading. Experimental Cell Research. 233(1). 78–87. 12 indexed citations
19.
Xu, Haitan, et al.. (1996). Characterization of murine intercellular adhesion molecule-2. The Journal of Immunology. 156(12). 4909–4914. 48 indexed citations
20.
Carpenito, Carmine, et al.. (1989). Molecular cloning of murine intercellular adhesion molecule (ICAM-1).. The EMBO Journal. 8(10). 2889–2896. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026